MAIA director granted 32,630 stock options
MAIA Biotechnology director Louie Ngar Yee received a grant of stock options on common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MAIA Biotechnology director Louie Ngar Yee received a grant of stock options on common shares. The award covers 32,630 options with an exercise price of $1.44 per share, granted under the company’s 2021 Equity Incentive Plan. The options vest 100% on the grant date and are immediately exercisable, expiring on June 30, 2036. Following this grant, Louie Ngar Yee holds 32,630 derivative securities directly.
Insider Trade Summary
Grant/Award: 32,630 shares
Grant/Award
1 txn
Insider
Louie Ngar Yee
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 32,630 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options — 32,630 contracts (Direct)
Footnotes (1)
- F1. The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Key Figures
Stock options granted: 32,630 options
Exercise price: $1.44 per share
Expiration date: June 30, 2036
+2 more
5 metrics
Stock options granted
32,630 options
Grant on June 30, 2026 to director Louie Ngar Yee
Exercise price
$1.44 per share
Exercise price of granted MAIA stock options
Expiration date
June 30, 2036
Options expire ten years after grant
Post-grant derivative holdings
32,630 derivative securities
Total stock options held after transaction
Vesting
100% on grant date
Options vest fully on June 30, 2026
Key Terms
Stock Options, 2021 Equity Incentive Plan, exercise price, vest 100% on the date of the grant, +1 more
5 terms
Stock Options financial
"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
2021 Equity Incentive Plan financial
"granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan"
exercise price financial
"conversion_or_exercise_price: "1.4400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest 100% on the date of the grant financial
"representing the right to buy shares of common stock, vest 100% on the date of the grant"
derivative securities financial
"total_shares_following_transaction: "32630.0000" for derivative-type security"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MAIA (MAIA) director Louie Ngar Yee report?
Louie Ngar Yee reported receiving a grant of 32,630 stock options on MAIA common stock. The options were awarded as compensation and are immediately exercisable, giving the right to buy shares at a fixed exercise price of $1.44 per share.
What is the exercise price of Louie Ngar Yee’s MAIA stock options?
The granted stock options carry an exercise price of $1.44 per share. This means Louie Ngar Yee can purchase MAIA common stock at $1.44, regardless of future market price, as long as the options are exercised before their expiration date.
When do Louie Ngar Yee’s MAIA stock options vest and become exercisable?
The stock options vest 100% on the June 30, 2026 grant date and are exercisable beginning that same day. This immediate vesting allows Louie Ngar Yee to exercise the right to buy MAIA common shares as soon as the award is granted.
When do the MAIA stock options granted to Louie Ngar Yee expire?
The stock options granted to Louie Ngar Yee expire on June 30, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to purchase MAIA common stock at the $1.44 exercise price.
How many MAIA derivative securities does Louie Ngar Yee hold after this option grant?
Following this transaction, Louie Ngar Yee holds 32,630 derivative securities related to MAIA common stock. These represent the full amount of the new stock option grant reported, held directly after the award under the company’s 2021 Equity Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates